Grogen 0.15% Ophthalmic Gel
Marketer
Growell Vision
Salt Composition
Ganciclovir (0.15% w/w)
Overview Grogen 0.15% Ophthalmic Gel
Cidofovir 0.15% ophthalmic gel is an antiviral medication indicated for treating cytomegalovirus (CMV) infections in immunocompromised individuals post-organ or bone marrow transplant. This treatment also mitigates the risk of vision loss from CMV retinitis, a severe ocular infection. Apply the gel externally only, as directed by your physician. Always wash hands before and after administration. Hold the applicator near the eye, avoiding contact, gently dispensing the gel into the lower conjunctival sac. Minor, transient eye irritation may occur; however, this typically resolves spontaneously. Report persistent irritation to your doctor. Refrain from contact lens use during treatment.
Uses of Grogen 0.15% Ophthalmic Gel
CMV Infection
Major Benefits of Grogen 0.15% Ophthalmic Gel:
Apply this medication externally only. Follow your physician's instructions regarding dosage and treatment length. Always consult the product label prior to application. Keep the applicator near, but not touching, the eye. Carefully dispense the medication into the lower eyelid sac by gently pressing the tube.
Common Side effects of Grogen 0.15% Ophthalmic Gel:
- Eye irritation
How to use Grogen 0.15% Ophthalmic Gel:
Apply this medication externally only. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details prior to use. Keep the applicator tip near, but not touching, the eye. Gently dispense the medication into the lower conjunctival sac.
How Grogen 0.15% Ophthalmic Gel works:
Opticlear 0.15% ophthalmic gel combats viral eye infections with its antiviral action. The gel inhibits viral replication on the cornea, thus halting further virus production and resolving the infection.
SAFETY ADVICE
AlcoholNone
No drug interactions identified.
PregnancyCONSULT YOUR DOCTOR
The use of Grogen 0.15% Ophthalmic Gel during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Grogen 0.15% Ophthalmic Gel while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Using Grogen 0.15% Ophthalmic Gel may induce adverse reactions that impair driving ability. These may include drowsiness, dizziness, confusion, tremors, loss of equilibrium, or seizures.
KidneyNone
No drug interactions identified.
LiverNone
No known drug interactions.
What if you forget to take Grogen 0.15% Ophthalmic Gel :
Should you forget a dose of Grogen 0.15% Ophthalmic Gel, apply it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed application and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Grogen 0.15% Ophthalmic Gel
| Label | Value |
|---|---|
| Chemical Category | Base analog |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Non-HIV antiviral medications |
3,018 People bought this recently